Didier Blondel
Finanzdirektor/CFO bei ABIVAX
Vermögen: 5 903 $ am 30.04.2024
Profil
Didier Blondel is currently the Chief Financial Officer, Secretary & EVP at Abivax SA since 2017.
Prior to his current position, he served as the Chief Financial Officer at MSD Vaccines GmbH from 2012 to 2016.
He also worked as an Auditor at PricewaterhouseCoopers France SARL.
From 2008 to 2011, he held the position of CFO-Research & Development at Sanofi-Aventis Groupe SA. Mr. Blondel completed his undergraduate and graduate studies at Nancy-Université and holds an MBA from ICN Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABIVAX SA
0,00% | 29.02.2024 | 374 ( 0,00% ) | 5 903 $ | 30.04.2024 |
Aktive Positionen von Didier Blondel
| Unternehmen | Position | Beginn |
|---|---|---|
| ABIVAX | Finanzdirektor/CFO | 02.01.2017 |
Ehemalige bekannte Positionen von Didier Blondel
| Unternehmen | Position | Ende |
|---|---|---|
MSD Vaccines GmbH
 MSD Vaccines GmbH Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD GmbH is an Austrian company that manufactures and distributes vaccines. The joint venture company is based in Brunn am Gebirge, Austria. The company was founded in 1994. The CEO is Oliver Sadlek. | Finanzdirektor/CFO | 01.12.2016 |
Sanofi-Aventis Groupe SA
 Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Corporate Officer/Principal | 01.12.2011 |
PricewaterhouseCoopers France SARL
 PricewaterhouseCoopers France SARL Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers France provides accounting and business management consulting services. It offers expertise in auditing, financial strategy, legal advise, and investment. The company was founded on May 30, 1963 and is headquartered in Neuilly-sur-Seine, France. | Comptroller/Controller/Auditor | - |
Ausbildung von Didier Blondel
| ICN Business School | Masters Business Admin |
| Nancy-Université | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABIVAX | Health Technology |
| Private Unternehmen | 3 |
|---|---|
MSD Vaccines GmbH
MSD Vaccines GmbH Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD GmbH is an Austrian company that manufactures and distributes vaccines. The joint venture company is based in Brunn am Gebirge, Austria. The company was founded in 1994. The CEO is Oliver Sadlek. | Health Technology |
PricewaterhouseCoopers France SARL
PricewaterhouseCoopers France SARL Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers France provides accounting and business management consulting services. It offers expertise in auditing, financial strategy, legal advise, and investment. The company was founded on May 30, 1963 and is headquartered in Neuilly-sur-Seine, France. | Commercial Services |
Sanofi-Aventis Groupe SA
Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Finance |
